McCall had been serving as interim CFO while in his previous position as an associate director of Craig Corporate Ltd., a specialist financial consultancy firm based in Glasgow.
Prior to Craig Corporate, Gordon served as a finance business partner at Texas Instruments' manufacturing plant in Greenock, where he was a member of the UK finance team responsible for facilities improvement, financial modeling, accounting and taxation.
He also worked as a decision support manager at Royal Bank of Scotland.
McCall is a chartered accountant and holds a 1st class accountancy degree from the University of Glasgow.
Dotmatics tailors solutions to the modern, highly collaborative and mobile scientific environments of several vertical markets, including the pharmaceutical, biotechnology, academia, food and beverage, oil and gas, and agrochemical industries.
Its enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organisations, from discovery research to development and early manufacturing.
Dotmatics has expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation.
The company's solutions are available for local or cloud deployment and supported on Microsoft Windows, Mac OS X and Linux.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business